$0.00
Global Continuous Glucose Monitoring (CGM) Market Analysis
Report Preview
Continuous Glucose Monitoring (CGM) market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.
Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Continuous Glucose Monitoring (CGM) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Continuous Glucose Monitoring (CGM) manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Continuous Glucose Monitoring (CGM) market covering all its essential aspects.
Global Continuous Glucose Monitoring (CGM) Market: Segmentations
Global Continuous Glucose Monitoring (CGM) Market: By Key Players
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Global Continuous Glucose Monitoring (CGM) Market: By Types
Transmitters
Sensors
Insulin Pumps
Global Continuous Glucose Monitoring (CGM) Market: By Applications
Hospitals
Homecare Settings
Global Continuous Glucose Monitoring (CGM) Market: Regional Analysis
The countries covered in the regional analysis of the Global Continuous Glucose Monitoring (CGM) market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Continuous Glucose Monitoring (CGM) market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Continuous Glucose Monitoring (CGM) would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Continuous Glucose Monitoring (CGM) Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
ToC
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Continuous Glucose Monitoring (CGM) Revenue
1.4 Market Analysis by Type
1.4.1 Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by Type: 2023 VS 2032
1.4.2 Transmitters
1.4.3 Sensors
1.4.4 Insulin Pumps
1.5 Market by Application
1.5.1 Global Continuous Glucose Monitoring (CGM) Market Share by Application: 2023-2032
1.5.2 Hospitals
1.5.3 Homecare Settings
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Continuous Glucose Monitoring (CGM) Market
1.8.1 Global Continuous Glucose Monitoring (CGM) Market Status and Outlook (2017-2032)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Continuous Glucose Monitoring (CGM) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Continuous Glucose Monitoring (CGM) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Continuous Glucose Monitoring (CGM) Sales Volume Market Share by Region (2017-2022)
3.2 Global Continuous Glucose Monitoring (CGM) Sales Revenue Market Share by Region (2017-2022)
3.3 North America Continuous Glucose Monitoring (CGM) Sales Volume
3.3.1 North America Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.3.2 North America Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 East Asia Continuous Glucose Monitoring (CGM) Sales Volume
3.4.1 East Asia Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.4.2 East Asia Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.5.1 Europe Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.5.2 Europe Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 South Asia Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.6.1 South Asia Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.6.2 South Asia Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Southeast Asia Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.7.1 Southeast Asia Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.7.2 Southeast Asia Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 Middle East Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.8.1 Middle East Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.8.2 Middle East Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.9 Africa Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.9.1 Africa Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.9.2 Africa Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.10 Oceania Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.10.1 Oceania Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.10.2 Oceania Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.11 South America Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.11.1 South America Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.11.2 South America Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.12 Rest of the World Continuous Glucose Monitoring (CGM) Sales Volume (2017-2022)
3.12.1 Rest of the World Continuous Glucose Monitoring (CGM) Sales Volume Growth Rate (2017-2022)
3.12.2 Rest of the World Continuous Glucose Monitoring (CGM) Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
4 North America
4.1 North America Continuous Glucose Monitoring (CGM) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Continuous Glucose Monitoring (CGM) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Continuous Glucose Monitoring (CGM) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Continuous Glucose Monitoring (CGM) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Continuous Glucose Monitoring (CGM) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Continuous Glucose Monitoring (CGM) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Continuous Glucose Monitoring (CGM) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Continuous Glucose Monitoring (CGM) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Continuous Glucose Monitoring (CGM) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Continuous Glucose Monitoring (CGM) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Continuous Glucose Monitoring (CGM) Sales Volume Market Share by Type (2017-2022)
14.2 Global Continuous Glucose Monitoring (CGM) Sales Revenue Market Share by Type (2017-2022)
14.3 Global Continuous Glucose Monitoring (CGM) Sales Price by Type (2017-2022)
15 Consumption Analysis by Application
15.1 Global Continuous Glucose Monitoring (CGM) Consumption Volume by Application (2017-2022)
15.2 Global Continuous Glucose Monitoring (CGM) Consumption Value by Application (2017-2022)
16 Company Profiles and Key Figures in Continuous Glucose Monitoring (CGM) Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer Continuous Glucose Monitoring (CGM) Product Specification
16.1.3 Pfizer Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.2 Baxter
16.2.1 Baxter Company Profile
16.2.2 Baxter Continuous Glucose Monitoring (CGM) Product Specification
16.2.3 Baxter Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.3 Abbott Laboratories
16.3.1 Abbott Laboratories Company Profile
16.3.2 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Specification
16.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.4 Medtronic
16.4.1 Medtronic Company Profile
16.4.2 Medtronic Continuous Glucose Monitoring (CGM) Product Specification
16.4.3 Medtronic Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.5 Animas
16.5.1 Animas Company Profile
16.5.2 Animas Continuous Glucose Monitoring (CGM) Product Specification
16.5.3 Animas Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.6 Novo Nordisk
16.6.1 Novo Nordisk Company Profile
16.6.2 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Specification
16.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.7 Ypsomed
16.7.1 Ypsomed Company Profile
16.7.2 Ypsomed Continuous Glucose Monitoring (CGM) Product Specification
16.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.8 GlySens
16.8.1 GlySens Company Profile
16.8.2 GlySens Continuous Glucose Monitoring (CGM) Product Specification
16.8.3 GlySens Continuous Glucose Monitoring (CGM) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
17 Continuous Glucose Monitoring (CGM) Manufacturing Cost Analysis
17.1 Continuous Glucose Monitoring (CGM) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM)
17.4 Continuous Glucose Monitoring (CGM) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Continuous Glucose Monitoring (CGM) Distributors List
18.3 Continuous Glucose Monitoring (CGM) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter’s Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Continuous Glucose Monitoring (CGM) (2023-2032)
20.2 Global Forecasted Revenue of Continuous Glucose Monitoring (CGM) (2023-2032)
20.3 Global Forecasted Price of Continuous Glucose Monitoring (CGM) (2017-2032)
20.4 Global Forecasted Production of Continuous Glucose Monitoring (CGM) by Region (2023-2032)
20.4.1 North America Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.2 East Asia Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.3 Europe Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.4 South Asia Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.5 Southeast Asia Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.6 Middle East Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.7 Africa Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.8 Oceania Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.9 South America Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.4.10 Rest of the World Continuous Glucose Monitoring (CGM) Production, Revenue Forecast (2023-2032)
20.5 Forecast by Type and by Application (2023-2032)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2023-2032)
20.5.2 Global Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Application (2023-2032)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.2 East Asia Market Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.3 Europe Market Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Countriy
21.4 South Asia Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.5 Southeast Asia Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.6 Middle East Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.7 Africa Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.8 Oceania Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.9 South America Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
21.10 Rest of the world Forecasted Consumption of Continuous Glucose Monitoring (CGM) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Quick Contact
+13217109863
info@markettreeresearch.com
